CHU de Saint Etienne
Saint-Etienne, 42055, France
NCT Number: NCT03355781
Childhood trauma is known as a vulnerability factor in schizophrenia. In healthy volunteers, these adversities are linked to a decrease of grey matter of the brain, similar to those observed in schizophrenia.
In a previous study based on Voxel-Based Morphometry (VBM), including 21 schizophrenic patients and 30 healthy volunteers, the investigators shown a negative correlation between emotional neglect (important dimension in childhood trauma) and grey matter decrease. This strong correlation was significantly higher in schizophrenic patients than in healthy volunteers, suggesting a higher genetic predisposition to environmental factors in schizophrenic people.
Currently, interaction between genetic predisposition and environmental stress factors is the major model for understanding in schizophrenia. In order to analyze both effects on human body, particularly on brain, several studies currently focus on the product of genetic expression, the ribonucleic acid (ARN).
The purpose of this study is to provide an explanatory model of links between childhood trauma, candidate gene for schizophrenia expression, cerebral morphology and schizophrenic symptomatology. Using conceptual framework of stress vulnerability, structural equation modeling (SEM) will allow testing causal link between these different variables.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
Saint-Etienne, 42055, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
of patients :
Exclusion criteria
of patients :
Inclusion criteria
of Related volunteers :
Exclusion criteria
of Related volunteers :
Inclusion criteria
of Healthy volunteers :
Exclusion criteria
of Healthy volunteers :
Beside the absence of schizophrenia diagnosis, healthy volunteers should meet the same exclusion criteria as patients
brain imaging : structural anatomy, emotional congruence, anatomic connectivity, functional connectivity
27,5 ml of blood sample : genetic analysis and biobank
Global Assessment Scale(GAS),Mini International Neuropsychiatric Interview(MINI),Positive and Negative Symptoms Scale(PANSS),Family Interview for Genetic Studies(FIGS),Calgary Depression Scale for Schizophrenia(CDSS),extrapyramidal side effects evaluation or Simpson-Angus scale evaluation(ESRS),Apathy Evaluation Scale(AES-C),State-Trait Anxiety Inventory(STAI),Beck Depression Inventory(BDI-13),Eysenck Personality Questionnaire-Revised(EPQ-R),Assessment of Schizotypal Personality(SPQ),Emotion Regulation Questionnaire(ERQ),Emotional Reactivity Scale(ERS),Toronto Alexithymia Scale(TAS-20),social anhedonia scale(SAS),Childhood Trauma Questionnaire(CTQ),Clinical-administered Post Traumatic Stress Disorder Scale(CAPS),Wechsler Adult Intelligence Scale(WAIS-III),Trail Making Test(TMT),Pen and paper visuospatial working memory(DOT-test),impulsivity test(GoStop),Stroop test,National Adult Reading Test(NART),Wechsler Adult Intelligence Scale(WAIS-III),Facial Emotion Recognition task(FER)
Time frame: 5 days
development of an etiopathogenic model characteristic of schizophrenia
Childhood Trauma Questionnaire : to assess five types of childhood trauma :
Each item being rated in 5 answer choice from 1 to 5 (never, rarely, sometimes, often or very often)
Time frame: 5 days
development of an etiopathogenic model characteristic of schizophrenia
Time frame: 5 days
development of an etiopathogenic model characteristic of schizophrenia
Time frame: 5 days
development of an etiopathogenic model characteristic of schizophrenia
Time frame: 5 days
Time frame: 5 days
Time frame: 5 days
symptomatic variables : PANSS scale
Time frame: 5 days
emotional variables : ERS scale, ERQ scale, TAS-20 scale, SAS scale, AES-C scale
Time frame: 5 days
personality characteristics : EPQ-R scale, SPQ scale
Time frame: 5 days
history of trauma in childhood : CTQ scale
Centre Hospitalier Universitaire de Saint Etienne
Other
Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology. SCHIZO' TRAUMA
Acronym: SCHIZO'TRAUMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05838573
Cognition Disorders, Cognitive Dysfunction
Changsha, Hunan, China
View Trial DetailsNCT05304767
Mental Disorders, Schizophrenia
Phoenix, Arizona, United States
View Trial DetailsNCT00004571
Mental Disorders, Normal Physiology
Bethesda, Maryland, United States
View Trial DetailsNCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial Details